greeksoup/ stock research

NU Skin Enterprises (NUS) Q1 FY2025 earnings: revenue $364 million, down 12.7% on the year

NU Skin Enterprises, Inc. (NUS) reported revenue of $364 million for Q1 FY2025, the quarter ended 31 March 2025, down 12.7% on the same quarter a year earlier. Net income was $108 million, and diluted earnings per share $2.14. The figures are the company's own, from the 10-Q it filed with the SEC on 9 May 2025.

Revenue$364 milliondown 12.7%
Net income$108 million
Diluted EPS$2.14
QuarterQ1 FY2025ended 31 March 2025

The quarter, against the one before and a year earlier

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Revenue364446417-12.7%
Cost of revenue118166123-4.6%
Gross profit247279294-16.0%
Gross margin67.8%62.7%70.5%
Operating income-9.9-53.18.8n/a
Operating margin-2.7%-11.9%2.1%
Interest expense3.35.97.3-55.2%
Pre-tax income135-57.81.1+12125.3%
Income tax27.1-21.71.6+1557.6%
Effective tax rate20.1%n/a148.4%
Net income108-36.1-0.5n/a
Net margin29.5%-8.1%-0.1%
Diluted EPS$2.14-$0.73-$0.01n/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Operating cash flow0.425.83.3-88.3%
Capital expenditure13.612.612.3+10.6%
Free cash flow-13.213.2-9.0n/a
Free cash flow margin-3.6%3.0%-2.1%
Cash from investing182-13.6-9.3n/a
Cash from financing-166-43.6-32.0n/a
Depreciation and amortisation14.216.418.4-22.9%
Share-based compensation9.33.44.2+119.4%
Buybacks5.00.00.0n/a
Dividends paid3.03.03.0+0.8%
Diluted shares, weighted50m50m50m+1.6%
Shares outstanding at period end49m50m50m-0.5%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Shareholders' equity754651810-6.9%
Debt239394483-50.6%
Operating lease liabilities61.958.474.2-16.5%
Finance lease liabilitiesn/a8.3n/an/a
Other liabilities337357374-10.0%
Total liabilities and equity1,3911,4691,742-20.1%
Fixed assets380380423-10.1%
Goodwill83.683.6231-63.8%
Intangible assets47.674.3102-53.3%
Investments9.850.78.7+12.8%
Cash and equivalents204187213-4.1%
Receivables56.650.867.0-15.6%
Inventory189190265-28.8%
Other assets421453433-2.7%
Total assets1,3911,4691,742-20.1%

Questions

What was NU Skin Enterprises' revenue in Q1 FY2025?

NU Skin Enterprises (NUS) reported revenue of $364 million for Q1 FY2025, the quarter ended 31 March 2025, down 12.7% on the same quarter a year earlier.

How much did NU Skin Enterprises earn in Q1 FY2025?

Net income for Q1 FY2025 was $108 million, and diluted earnings per share $2.14.

When did NU Skin Enterprises report Q1 FY2025 results?

NU Skin Enterprises filed its 10-Q for the quarter ended 31 March 2025 with the SEC on 9 May 2025.

Quarterly results, the last 20 quarters

Q3 FY2021Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue641673605561538522481500499489417439430446364386364370321320
Cost of revenue159174161148174148134136207136123132129166118120107108106102
Gross profit482500443413364375348365292352294307301279247266257262214218
Gross margin75%74%73%74%68%72%72%73%59%72%70%70%70%63%68%69%70%71%67%68%
Operating income65.420.352.151.5-20.327.516.142.5-26.416.18.8-12618.2-53.1-9.930.821.623.24.0-59.3
Operating margin10%3%9%9%-4%5%3%8%-5%3%2%-29%4%-12%-3%8%6%6%1%-19%
Interest expensen/an/an/an/an/an/a4.95.87.57.47.36.76.55.93.32.54.14.04.23.3
Pre-tax income68.218.450.742.9-29.024.414.637.1-34.59.31.1-13213.3-57.813527.416.018.22.6-63.2
Tax rate27%150%24%20%n/a-135%22%28%n/a22%148%n/a38%n/a20%23%-7%20%29%n/a
Net income49.7-9.238.734.2-25.457.211.426.9-37.07.3-0.5-1188.3-36.110821.117.114.51.8-250
Net margin8%-1%6%6%-5%11%2%5%-7%1%-0%-27%2%-8%29%5%5%4%1%-78%
Diluted EPS$0.97-$0.17$0.76$0.67-$0.51$1.15$0.23$0.54-$0.74$0.15-$0.01-$2.38$0.17-$0.73$2.14$0.43$0.34$0.29$0.04-$5.14
Operating cash flow30.21107.546.628.425.5-22.135.551.054.23.351.231.425.80.435.827.516.6-3.910.6
Capital expenditure13.518.210.39.525.513.811.514.711.920.412.38.18.612.613.60.09.910.813.75.6
Free cash flow16.791.3-2.737.03.011.7-33.620.839.133.8-9.043.122.813.2-13.235.817.65.9-17.65.0
Buybacks10.010.010.010.040.010.00.00.013.00.00.00.00.00.05.00.05.010.05.00.0
Dividends paid19.018.919.319.419.319.019.419.519.519.33.03.03.03.03.03.03.02.92.92.9
Shares outstanding50m50m50m50m49m49m50m50m49m49m50m50m50m50m49m49m49m48m49m49m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2025, filed 9 May 2025: the filing.